Erik Veskimäe
About
In The Last Decade
Erik Veskimäe
19 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Surgery 2.7k
- Urology 915
- Oncology 695
- Pulmonary and Respiratory Medicine 604
- Molecular Biology 569
Countries citing papers authored by Erik Veskimäe
This map shows the geographic impact of Erik Veskimäe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Veskimäe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Veskimäe more than expected).
Fields of papers citing papers by Erik Veskimäe
This network shows the impact of papers produced by Erik Veskimäe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Veskimäe. The network helps show where Erik Veskimäe may publish in the future.
Co-authorship network of co-authors of Erik Veskimäe
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Veskimäe. A scholar is included among the top collaborators of Erik Veskimäe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Veskimäe. Erik Veskimäe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma breakdown → | 212 |
| 3 | 4 | |
| 4 | 0 | |
| 5 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines breakdown → | 1278 |
| 6 | 21 | |
| 7 | 57 | |
| 8 | 93 | |
| 9 | 16 | |
| 10 | 2 | |
| 11 | 21 | |
| 12 | 30 | |
| 13 | 55 | |
| 14 | Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer breakdown → | 1090 |
| 15 | Muscle-invasive and Metastatic Bladder Cancer | 14 |
| 16 | 142 | |
| 17 | 2 | |
| 18 | 73 | |
| 19 | 24 | |
| 20 | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.